Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trialChan Joon Kim, Jong‐Seon Park, Mahn‐Won Park et al.|The Lancet|2021Cited by 202
Comparison of Biolimus A9–Eluting (Nobori) and Everolimus-Eluting (Promus Element) Stents in Patients With De Novo Native Long Coronary Artery LesionsJong‐Young Lee, Seung‐Jung Park, Sung Yun Lee et al.|Circulation Cardiovascular Interventions|2014Cited by 34
Dual Antiplatelet Therapy De-Escalation in Stabilized Myocardial Infarction With High Ischemic RiskMyunhee Lee, Jang Hoon Lee, Sungwook Byun et al.|JAMA Cardiology|2023Cited by 10
Acute Myocardial Infarction Is a Risk Factor for New Onset Diabetes in Patients with Coronary Artery DiseaseChul Soo Park, Hyuk‐Sang Kwon, Woo Baek Chung et al.|PLoS ONE|2015Cited by 9
Comparison of Resolute zotarolimus-eluting and Xience everolimus-eluting stents in patients with de novo long coronary artery lesionsDo‐Yoon Kang, Seung‐Jung Park, Cheol Hyun Lee et al.|Coronary Artery Disease|2018Cited by 9